IND 205B: A phase II study of the PI3K inhibitor PX-866 and continued abiraterone/prednisone in patients with recurrent or metastatic castration resistant prostate cancer (CRPC) with PSA progression on abiraterone/prednisone. Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Hotte, Sebastien
  • Joshua, Anthony M
  • Torri, Vamsee
  • Macfarlane, Robyn Jane
  • Basappa, Naveen S
  • Powers, Jean
  • Winquist, Eric
  • Mukherjee, Som
  • Gregg, Richard William
  • Kollmannsberger, Christian K
  • Finch, Daygen L
  • Xu, Hao
  • Hausman, Diana Felice
  • Seymour, Lesley
  • Eisenhauer, Elizabeth A
  • Chi, Kim N

publication date

  • March 2015